Dual IL-17A and IL-17F macrocyclic peptide inhibitor therapy (PeptiDream)

N/A

Report date: 2025/12/18 17:03:53
NME

Base Information

Drug NameDual IL-17A and IL-17F macrocyclic peptide inhibitor therapy (PeptiDream)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionInterleukin 17A inhibitorsInterleukin-17F inhibitors
TargetsInterleukin 17AInterleukin-17F
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPeptiDream Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeptiDream Inc
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A